Log in to save to my catalogue

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for...

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2725190752

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma

About this item

Full title

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2022-11, Vol.41 (47), p.5061-5075

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Ubiquitin specific peptidase 7 (USP7) is a deubiquitinating enzyme (DUB) that removes ubiquitin tags from specific target protein substrates in order to alter their degradation rate, sub-cellular localization, interaction, and activity. The induction of apoptosis upon USP7 inhibition is well established in cancer containing wild type p53, which ope...

Alternative Titles

Full title

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2725190752

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2725190752

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-022-02486-5

How to access this item